Tofacitinib for the treatment of alopecia areata in preadolescent children - 14/01/19
Funding sources: Dr King received support from the Ranjini and Ajay Poddar Resource Fund for Dermatologic Diseases Research. |
|
Disclosure: Dr Craiglow has served on advisory boards, received honoraria from, and is a consultant to Pfizer. Dr King has served on advisory boards for Pfizer and Aclaris Therapeutics and is a consultant to Pfizer, Concert Pharmaceuticals, and Eli Lilly and Company. |
Vol 80 - N° 2
P. 568-570 - février 2019 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?